The human leukocyte antigen complex and chronic ocular inflammatory disorders

American Journal of Ophthalmology

Volumn 129, Issue 2, 2000, Pages 235-243

  Davey, Michael P ^a,c,d   Rosenbaum, James T ^b,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b CASEY EYE INSTITUTE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ALLELISM; ANIMAL CELL; AUTOIMMUNITY; EYE INFLAMMATION; GENE LOCUS; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; MOLECULAR MIMICRY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0033968181     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00433-X     Document Type: Article

References (56)

1. Agardh D., Gaur L.K., Agardh E., Landin-Olsson M., Agardh C.D., Lernmark A. HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM. Diabetologia. 39:1996;1313-1317.
2. Yanagama T., Mangklabruks A., Chang Y.B., et al. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab. 76:1991;1569-1574.
3. Hjelmstrom P., Giscombe R., Lefvert A.K., et al. Polymorphic amino acid domains of the HLA-DQ molecule are associated with disease heterogeneity in myasthenia gravis. J Neuroimmunol. 65:1996;125-131.
4. Mondino B.J., Brown S.I., Rabin B.S. HLA antigens in ocular cicatricial pemphigoid. Arch Ophthalmol. 97:1979;479.
5. Hillert J., Kall T., Olerup O., Soderstrom M. Distribution of HLA-Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity. Acta Neurologica Scandinavica. 94:1996;161-166.
6. Gil-Carrasco F., Vargas-Alarcon G., Zuniga J., et al. HLA-DRB and HLA-DQB loci in the genetic susceptibility to develop glaucoma in Mexicans. Am J Ophthalmol. 128:1999;297-300.
7. Kang H.I., Fei H.M., Saito I., et al. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome. J Immunol. 150:1993;3615-3623.
8. Mondino B.J., Brown S.I., Biglan A.W. HLA antigens in Stevens-Johnson syndrome with ocular involvement. Arch Ophthalmol. 100:1982;1453-1454.
9. Combe B., Sany J., Le Quellec A., Clot J., Eliaou J.F. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population. J Rheumatol. 25:1998;94-98.
10. Matsuo T., Matsuo N. HLA-DR9 associated with the severity of acute retinal necrosis syndrome. Ophthalmologica. 203:1991;133-137.
11. Holland G.N., Cornell P.J., Park M.S., et al. An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62,DR4. Am J Ophthalmol. 108:1989;370-374.
12. Koumantaki Y., Stavropoulos C., Spyropoulou M., et al. HLA-B*5101 in Greek patients with Behcet's disease. Hum Immunol. 59:1998;250-255.
13. Tabary T., Lehoang P., Betuel H., et al. Susceptibility to birdshot chorioretinopathy is restricted to the HLA-A29.2 subtype. Tissue Antigens. 36:1990;177-179.
14. Nussenblatt R.B., Mittal K.K., Ryan S., Green W.R., Maumenee A.E. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol. 94:1982;147-158.
15. Lyons J.L., Rosenbaum J.T. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol. 115:1997;61-64.
16. Glass D., Litvin D., Wallace K., et al. Early-onset pauciarticular juvenile rheumatoid arthritis associated with human leukocyte antigen-DRw5, iritis, and antinuclear antibody. J Clin Invest. 66:1980;426-429.
17. Malinowski S.M., Pulido J.S., Goeken N.E., Brown C.K., Folk J.C. The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology. 100:1993;1199-1205.
18. Meredith T.A., Smith R.E., Duquesnoy R.J. Association of HLA-DRw2 antigen with presumed ocular histoplasmosis. Am J Ophthalmol. 89:1980;70-76.
19. Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT. Characterization of uveitis in patients with psoriatic arthritis. Ann Rheum Dis. Forthcoming.
20. Brewerton D.A., Caffrey M., Nicholls A., Walters D., James D.C. Acute anterior uveitis and HL-A 27. Lancet. 2:1973;994-996.
21. Islam S.M., Numaga J., Fujino Y., et al. HLA class II genes in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 35:1994;3890-3896.
22. Weisz J.M., Holland G.N., Roer L.N., et al. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanics living in southern California. Ophthalmology. 102:1995;1012-1015.
23. Sebzda E., Mariathasan S., Ohteki T., et al. Selection of the T cell repertoire. Annu Rev Immunol. 17:1999;829-874.
24. Germain R.N. MHC-dependent antigen processing and peptide presentation providing ligands for T lymphocyte activation . Cell. 76:1994;287-299.
25. Schlosstein L., Terasaki P.I., Bluestone R., Pearson C.M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 288:1973;704-706.
26. Brewerton D.A., Hart F.D., Nicholls A., Caffrey M., James D.C., Sturrock R.D. Ankylosing spondylitis and HL-A 27. Lancet. 1:1973;904-907.
27. Tiwari J.L., Terasaki P.I. HLA and disease associations. 1985;Springer-Verlag, New York.
28. Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., Wiley D.C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 329:1987;506-512.
29. Goldberg A.L., Rock K.L. Proteolysis, proteasomes and antigen presentation. Nature. 357:1992;375-379.
30. Pamer E., Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu Rev Immunol. 16:1998;323-358.
31. Brown J.H., Jardetzky T.S., Gorga J.C., et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 364:1993;33-39.
32. Manoury B., Hewitt E.W., Morrice N., Dando P.M., Barrett A.J., Watts C. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature. 396:1998;695-699.
33. Benham A., Tulp A., Neefjes J. Synthesis and assembly of MHC-peptide complexes. Immunol Today. 16:1995;359-362.
34. Denzin L.K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell. 82:1995;155-165.
35. Denzin L.K., Sant'Angelo D.B., Hammond C., Surman M.J., Cresswell P. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science. 278:1997;106-109.
36. Campbell R.D., Trowsdale J. Map of the human MHC. Immunol Today. 14:1993;349-352.
37. Herberg J.A., Sgouros J., Jones T., et al. Genomic analysis of the Tapasin gene, located close to the TAP loci in the MHC. Eur J Immunol. 28:1998;459-467.
38. Engelhard V.H. Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol. 12:1994;181-207.
39. Jardetzky T.S., Lane W.S., Robinson R.A., Madden D.R., Wiley D.C. Identification of self peptides bound to purified HLA-B27. Nature. 353:1991;326-331.
40. van der Linden S.M., Valkenburg H.A., de Jongh B.M., Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals a comparison of relatives of spondylitis patients with the general population . Arthritis Rheum. 27:1984;241-249.
41. Wucherpfennig K.W., Strominger J.L. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules a mechanism for HLA-linked susceptibility to human autoimmune diseases . J Exp Med. 181:1995;1597-1601.
42. Allen R.L., O'Callaghan C.A., McMichael A.J., Bowness P. HLA-B27 can form a novel beta-2-microglobulin-free heavy chain homodimer structure. J Immunol. 162:1999;5045-5048.
43. Jameson S.C., Hogquist K.A., Bevan M.J. Positive selection of thymocytes. Annu Rev Immunol. 13:1995;93-126.
44. Nepom G.T., Kwok W.W. Molecular basis for HLA-DQ associations with IDDM. Diabetes. 47:1998;1177-1184.
45. Ridgway W.M., Fasso M., Fathman C.G. A new look at MHC and autoimmune disease. Science. 284:1999;749-751.
46. Carrasco-Marin E., Shimizu J., Kanagawa O., Unanue E.R. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol. 156:1996;450-458.
47. Buckner J., Kwok W.W., Nepom B., Nepom G.T. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions. J Immunol. 157:1996;4940-4945.
48. Ridgway W.M., Fasso M., Lanctot A., Garvey C., Fathman C.G. Breaking self-tolerance in nonobese diabetic mice. J Exp Med. 183:1996;1657-1662.
49. Douek D.C., McFarland R.D., Keiser P.H., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature. 396:1998;690-695.
50. Oldstone M.B. Molecular mimicry and autoimmune disease. Cell. 50:1987;819-820.
51. Gross D.M., Forsthuber T., Tary-Lehmann M., et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science. 281:1998;703-706.
52. Bottazzo G.F., Todd I., Mirakian R., Belfiore A., Pujol-Borrell R. Organ-specific autoimmunity a 1986 overview . Immunol Rev. 94:1986;137-169.
53. Streilein J.W., Dana M.R., Ksander B.R. Immunity causing blindness five different paths to herpes stromal keratitis . Immunol Today. 18:1997;443-449.
54. Avery A.C., Zhao Z.S., Rodriguez A., et al. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature. 376:1995;431-434.
55. Zhao Z.S., Granucci F., Yeh L., Schaffer P.A., Cantor H. Molecular mimicry by herpes simplex virus type 1 autoimmune disease after viral infection . Science. 279:1998;1344-1347.
56. Gangappa S., Babu J.S., Thomas J., Daheshia M., Rouse B.T. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. J Immunol. 161:1998;4289-4300.